Compound Heterozygous Mutations in the F7 Gene in 2 Unrelated Families With Congenital Factor VII Deficiency

J Pediatr Hematol Oncol. 2021 Nov 1;43(8):e1059-e1061. doi: 10.1097/MPH.0000000000002057.

Abstract

Factor VII (FVII) deficiency is a rare bleeding disorder normally caused by homozygous and compound heterozygous mutations in the F7 gene. Whole-exome sequencing was performed to identify F7 mutations in 3 individuals from 2 unrelated families who were diagnosed with FVII deficiency. Four compound heterozygous mutations were identified and validated in these 3 probands with FVII deficiency. Among the 4 identified mutations, NM_000131.4:c.572-1_581del, NM_000131.4:c.1250A>G (p.Tyr417Cys), and NM_000131.4:c.647G>T (p.Gly216Val) were novel. All 3 novel mutations were predicted to be likely pathogenic by the American College of Medical Genetics and Genomics/Association for Molecular Pathology guidelines.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Child
  • Factor VII / genetics*
  • Factor VII Deficiency / congenital
  • Factor VII Deficiency / genetics
  • Factor VII Deficiency / pathology*
  • Family
  • Female
  • Heterozygote*
  • Humans
  • Male
  • Mutation*
  • Prognosis

Substances

  • Factor VII